09/01/2026
Optiflex Trio trifocal IOL enhances vision, reduces aberrations, and supports spectacle independence*
The study (*Sharma N, Bari A, Shakkarwal C, Sharma G, Yadav A, Roop P, et al. Clinical assessment of visual outcomes and safety in Indian cataract patients implanted with the Optiflex Trio trifocal intraocular lens. Indian J. of Ophthalmology) demonstrates that Optiflex Trio trifocal IOL provides significant improvements in visual acuity, optical quality, and refractive outcomes following cataract surgery.
At 12 months postoperatively, patients exhibited enhanced near, intermediate, and distance vision, along with improved contrast sensitivity and a reduction in higher‑order aberrations, indicating stable postoperative visual function.
To read the whole abstract click on the following link:
https://biotechhealthcare.com/wp-content/uploads/2026/01/Namrata-Sharma-etal.-2025_optiflex-trio.pdf